ວັນທີ 4 ກຸມພາ 2022: ໃນປະເທດອິນເດຍ, ມະເຮັງສາມາດສົ່ງຜົນກະທົບທີ່ຮ້າຍແຮງທາງດ້ານສັງຄົມແລະເສດຖະກິດ, ໂດຍທົ່ວໄປແລ້ວເຮັດໃຫ້ຄວາມທຸກຍາກໃນຄອບຄົວແລະຄວາມບໍ່ຍຸຕິທໍາໃນສັງຄົມ. ໃນປະເທດທີ່ຍັງອ່ອນຢູ່ໃນປະເທດນີ້, ອັດຕາການເກີດມະເຮັງປັບຕາມອາຍຸການລາຍງານແມ່ນຍັງຕ່ໍາພໍສົມຄວນ. ໃນປະຊາກອນ 1.3 ຕື້ຄົນ, ເລັກນ້ອຍຫຼາຍກ່ວາ 1 ລ້ານກໍລະນີຂອງມະເຮັງໃຫມ່ໄດ້ຖືກກວດພົບໃນແຕ່ລະປີ. ໃນເງື່ອນໄຂການປັບແຕ່ງອາຍຸ, ນີ້ສະແດງໃຫ້ເຫັນປະມານຫນຶ່ງສີ່ຂອງອຸປະຕິເຫດຂອງຜູ້ຊາຍແລະແມ່ຍິງທີ່ມີຢູ່ໃນເອີຣົບຕາເວັນຕົກ. ໃນທາງກົງກັນຂ້າມ, ມະເຮັງແມ່ນຮັບຜິດຊອບຕໍ່ການເສຍຊີວິດປະມານ 600000-700000 ໃນປະເທດອິນເດຍໃນປີ 2012.
ອີງຕາມການວິເຄາະລະດັບໂລກຂອງພະຍາດຂອງການສຶກສາ 2019 ຂອງ IHME, ຮູບພາບບໍ່ແຕກຕ່າງກັນໂດຍສະເພາະໃນທົ່ວໂລກ. ໃນປີ 2019, ຈໍານວນກໍລະນີມະເຮັງໃຫມ່ໄດ້ລື່ນກາຍ 23 ລ້ານຄົນ, ເພີ່ມຂຶ້ນຈາກ 18.7 ລ້ານຄົນໃນປີ 2010. ໃນປີ 2019 ມີຜູ້ເສຍຊີວິດຈາກພະຍາດມະເຮັງ 10 ລ້ານຄົນ, ເພີ່ມຂຶ້ນຈາກ 8.29 ລ້ານຄົນໃນປີ 2010. ຜົນໄດ້ຮັບເຫຼົ່ານີ້ສະແດງໃຫ້ເຫັນເຖິງ 20.9 ເປີເຊັນ ແລະ ເພີ່ມຂຶ້ນ 26.3 ເປີເຊັນຕາມລໍາດັບ. .
In both developing and developed countries, cancer is a leading cause of morbidity and mortality. The majority of the population in many low- and middle-income nations, including India, does not have access to a well-organized and well-regulated cancer care system. When a person is diagnosed with cancer, they are often forced to spend a lot of money on their own health. Such expenses can push entire families into poverty and, when paired with a lack of what are considered acceptable services, can jeopardize social stability. It can be easily said that cancer treatment in India is still in a nascent stage and huge development is required in this field.
There are two major problems cancer patients and their family members face when someone is diagnosed with cancer. One is, where will they get the best and most appropriate treatment, and two, how much money will be required for treatment? Second is the most important question, as the general population in India is still devoid of health insurance. We at CancerFax addresses both these problems. We help cancer patients find most appropriate and economical cancer treatment in India and abroad. CancerFax is working with more than 100 top cancer hospitals in 10 countries like Dana-Farber, Mayo Clinic, Boston Children’s Hospital, Sheba, Asan, Apollo, BLK, Artemis to name a few.
CAR T-Cell therapy is a breakthrough treatment for some kinds of lymphoma, leukemia and multiple myeloma. CancerFax helps patients enroll for ການປິ່ນປົວດ້ວຍ T-Cell treatment in the USA, Israel and China. Many patients who had previously relapsed blood tumors had no evidence of cancer after CAR T-Cell therapy. It has also aided in the rehabilitation of patients who have previously failed to respond to most traditional cancer therapies. There are more than 300 ongoing clinical trials in the world’s leading cancer centers on this therapy. CAR T-Cell therapy in India is available as clinical trials now. I hope it will be available for commercial treatment very soon.
